Zdrowie i gospodarka · 13/03/2024
FDA Clears Path for Approval of Romidepsin Injection Formulations
The FDA has determined that two formulations of Romidepsin Injection were not withdrawn from sale due to safety or effectiveness concerns, allowing for the approval of abbreviated new drug applications for these formulations.